BioTech
FDA has some safety concerns about CRISPR-based sickle cell treatment, documents show
The Food and Drug Administration said on Friday that it has some safety concerns about an experimental CRISPR-based treatment for sickle cell disease, citing the
Adam Feuerstein and Megan Molteni
October 27, 2023